NEWS!

We are developing
blood cells for
research of COVID-19!

We are developing a human white blood cells based on Mylc cell optimized for the evaluation of the efficacy and safety of vaccines and drugs for COVID-19, which is shaking the world!
High precision and uniform blood cells produced using regenerative medicine technologies drastically accelerate the evaluation of the efficacy of drugs for COVID-19.
(Please contact us for details.)

NEWS

2020.09.09

New Product Release

2020.08.24

Company Presentation at 134th Morning Meet Up on web.

2020.08.19

Presentation on ChinaBio Partnering Forum 2020

2020.08.16

Presentation on Joint international tropical medicine meeting Virtual 2020

We are providing high precision immature blood cells developed for various types of evaluation of drugs and
functional materials for cosmetics and foods,
and offer a contract evaluation service using the blood cells.

More information on the products

More information on the evaluation services